SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-009342
Filing Date
2019-03-26
Accepted
2019-03-26 16:10:42
Documents
5
Effectiveness Date
2019-03-26

Document Format Files

Seq Description Document Type Size
1 S-8 phas-s8.htm S-8 131886
2 EX-5.1 phas-ex51_7.htm EX-5.1 15388
3 EX-23.1 phas-ex231_6.htm EX-23.1 2576
4 GRAPHIC gfmydxp1nmuw000001.jpg GRAPHIC 2395
5 GRAPHIC gfmydxp1nmuw000002.jpg GRAPHIC 2390
  Complete submission text file 0001564590-19-009342.txt   157972
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230504 | Film No.: 19705407
SIC: 2834 Pharmaceutical Preparations